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Pulsed laser deposition was proved as a suitable method for hydroxyapatite (HA) coating of coaxial poly-ε-caprolactone/poly-
vinylalcohol (PCL/PVA) nanofibers. The fibrous morphology of PCL/PVA nanofibers was preserved, if the nanofiber scaold was
coated with thin layers of HA (200 nm and 400 nm). Increasing thickness of HA, however, resulted in a gradual loss of fibrous
character. In addition, biomechanical properties were improved after HA deposition on PCL/PVA nanofibers as the value of
Young’s moduli of elasticity significantly increased. Clearly, thin-layer hydroxyapatite deposition on a nanofiber surface stimulated
mesenchymal stem cell viability and their dierentiation into osteoblasts. The optimal depth of HA was 800 nm.
1. Introduction
Stem cells have undoubtedly been at the center of interest
and the object of intensive study in the last decade [1–3].
Clearly, multiple stem cells have, under suitable conditions,
the potential to dierentiate cell lineages and thus play a key
role in tissue engineering and regenerative medicine. Several
sources of stem cells have been described, including muscle
[4, 5], synovium [6], periosteum [7], and bone marrow [8,
9]. Stem cells can be also isolated from adipose tissue, which
can be obtained under local anesthesia with minimal discom-
fort [10, 11]. However, bone marrow is most widely utilized
as a source of autologous MSCs. These cells can dierentiate
into osteogenic lineages when cultured in the presence of
dexamethasone, ascorbic acid, and β-glycerophosphate [12]
and potentially used for treating large bone defects. Autol-
ogous stem cells as the source of donor cells have numerous
advantages for regenerative medicine. These include low do-
nor site morbidity, a diminished or absent immune response,
and a high proliferative potential [1, 2].
In fact, other growth factors such as transforming growth
factor (TGF-β), insulin-like growth factor (IGF), and basic
fibroblast growth factor (bFGF) have been described as stim-
ulators of MSCs proliferation and osteogenic dierentiation
[13, 14]. The process of stem cell dierentiation is un-
doubtedly complicated and time and concentration depen-
dent. Thus, the main challenge of the successful application
of MSCs in regenerative medicine seems to be the regulated
release of a suitable concentration of dierentiation factors,
particularly under in vivo conditions. This is among the goals
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of tissue engineering as a multidisciplinary field focusing
on the reconstruction of biological tissues. Cells, especial-
ly autologous cells, and smart (functionalized) scaolds en-
riched with growth factors, preferentially serving as a con-
trolled delivery device, are fundamental components in the
engineering of novel cell proliferation and dierentiation
systems [2].
Surface modification is one of the essential steps in con-
structing artificial cell-seeded systems. HA, which is similar
to the apatite of living bone, can be used as a suitable ma-
terial for improving cell proliferation and dierentiation into
osteoblasts. HA has been used in medicine and dentistry
for over 20 years due to its biocompatibility and osteocon-
ductivity and its excellent chemical and biological anity
with bone tissue [15, 16]. HA coatings of bone implants
enable fast bony adaptation and reduced healing time [17–
19]. There are a number of techniques used to produce thin
HA films. Plasma-sprayed HA coatings, where HA is bound
mechanically, have limited chemical bonding, and cracks,
pores, and other impurities limit their mechanical strength
in contact with a substrate and the stability of the layer
[20, 21]. Another coating technique is ion beam sputtering,
producing an amorphous coating. Subsequently, heat treat-
ment is necessary to produce crystals [22, 23]. Very high
temperatures, necessary for crystallization, are not favorable
for nonmetallic materials such as polymers or bioactive mol-
ecules. Pulsed laser deposition (PLD) is mostly used as an
alternative technique of HA coating [24, 25]. PLD employs
an intense laser beam for material evaporation. Subsequent
condensation on a mat can create a very thin layer (depth of
several atoms only). The material surface properties are, con-
sequently, directly dependent on the deposition conditions.
Aside from chemical and surface charge modification,
the surface’s physical properties are also vital for successful
cell seeding on scaolds. Nanotechnology is the term used to
cover the design, construction, and utilization of functional
structures with at least one characteristic dimension mea-
sured in nanometers and brings a new chance to stem cells
research and development [26–28].
Electrospun nanofibers are novel materials characterized
by an enormous surface to volume ratio, high porosity, and
a structure resembling that of the extracellular matrix, thus
facilitating their use in a broad range of applications [29, 30].
These properties predestined the use of nanofibers in various
tissue engineering applications. In addition, nanofibers can
also serve as drug delivery systems. Nanofibers have been
utilized for the delivery of both water soluble and water
insoluble substances [31, 32]. Due to their enormous surface
area, nanofibers enable the adhesion of diverse bioactive
agents, such as growth factors [33], enzymes [34], or nucleic
acids [35]. The release kinetics of the content is determined
by the form of the interaction between the fibers and the
adhered drug. If the drug is noncovalently attached to the
nanofiber surface, the interaction is weak, and a quick burst
release occurs. For nonbiodegradable materials, the diu-
sion rate of the drug from the fibers depends strongly on
the physiochemical properties of the delivered substances,
such as the molecular weight, hydrophobicity, and charge
of the molecule. For biodegradable materials, the process
additionally depends also on the kinetics of the material’s de-
gradation, which for rapidly degradable materials is signifi-
cantly hastened [29]. Clearly, drugs dissolved or dispersed in
materials from which nanofibers are produced can be quickly
released. However, healing processes often require a slower
release on a scale of days or even weeks. This is especially
important in vivo.
To overcome this obstacle, the incorporation of bioac-
tive substances in the interior of the nanofiber has been
employed. This can be achieved either by blend electrospin-
ning or by coaxial electrospinning. Blend electrospinning is
a single-step method enabling the incorporation of various
bioactive substance [32]. The disadvantage of the process is
its limitation by the compatibility of the delivered substances
with the polymer solvent. Thus, blend electrospinning is not
suitable for the delivery of proteins with polymers soluble
only in organic solvents. Despite these constraints, blend
electrospinning is a fast and convenient method for the
microencapsulation of antibiotics [36, 37], anticancer drugs
[38–42], proteins [43–45], DNA [46, 47], and siRNA [48].
Recently, coaxial electrospinning was introduced as a novel
method for drug delivery resulting in the production of core-
shell nanofibers [49]. The nanofiber core and shell could
be prepared either from the same polymer solution or from
dierent polymer solutions, thus combining the advantages
of both polymer systems. Such systems could deliver highly
susceptive substances in combination with various polymer
systems without altering their structure or function. Electro-
spun coaxial fibers have been employed for the delivery of
various bioactive substances, for example, proteins [50–52],
DNA [46], and siRNA [48]. In addition, further drug encap-
sulation in the nanofiber core, such as in liposomes, can sig-
nificantly prolong drug release from the nanofiber interior.
The aim of the present study was to introduce a modern
system suitable for the treatment of bone defects. This sys-
tem is based on MSCs and functionalized nanofibers. The na-
nofibers can be modified on their surface as well as enriched
in their core with dierent drugs that could be slowly released
over the course of days or weeks.
2. Methods
2.1. Materials and Reagents. Poly-ε-caprolactone (PCL, MW
45000), FITC-dextran, MTT, glycerol 2-phosphate disodium
salt hydrate, BCECF-AM, and PCR primers were purchased
from Sigma-Aldrich (Germany). Polyvinylalcohol sloviol
(PVA) was purchased from Novacke Chemicke Zavody
(Slovak republic). Hydroxyapatite was obtained in the form
of a pressed powder (Lasak, Czech Republic). Gelofusine was
purchased from B. Braun Melsungen (Germany). α-MEM
cultivation medium and foetal bovine serum were purchased
from PAA (Austria). Double-strand-specific dye for PCR
analysis, SYBR Green I, was purchased from Roche (Roche
Diagnostics, Mannheim, Germany) and an RNeasy Mini Kit
for RNA isolation from Qiagen (Germany).
2.2. Coaxial Electrospinning of PCL/PVA Nanofibers. A 14%
(w/v) PCL solution was prepared as the shell solution by
dissolving 7 g PCL in 50 mL chloroform/ethanol (8 : 2) and
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stirring at room temperature. The core solution consisted
of 5% PVA (v/v). The coaxial spinneret apparatus consisted
of two needles placed together coaxially [53]. Two syringe
pumps were used to deliver the core and shell solutions, re-
spectively. A high-voltage power supply was used to generate
voltages of up to 60 kV, and a span bond was used as the re-
ceiving plate to collect the electrospun nanofibers. The dis-
tance between the tip of the syringe needle and the collecting
plate was 12 cm. All electrospinning processes were per-
formed at room temperature with 56% humidity. In case of
the release study, the core solution consisted of FITC-dextran
(2 mg/mL, 10,000 MW) dissolved either in 1%, 3%, or 5%
(v/v) PVA. The process was performed on the apparatus de-
scribed above at room temperature with 52% humidity.
2.3. HA Coatings of Nanofibers. Prepared nanofibers
were coated by HA layers of dierent thickness. HA
[Ca10(PO4)6(OH)2] films were created by a KrF excimer
laser (COMPexPro 205 F) of 248 nm wavelength, frequency
10 Hz, and energy 600 mJ. The energy density of the laser
beam was 2 Jcm−2. The deposition proceeded in an H2O +
Ar atmosphere at a pressure of 40 Pa. The substrate was fixed
at a distance of 5 cm from the target HA material (cake of
pressed powder). The substrate was at room temperature.
HA films of 200 (PCL/PVA200HA), 400 (PCL/PVA400HA),
and 800 nm thickness (PCL/PVA800HA) were grown. Pure
PCL/PVA core-shell nanofibers were used as a control (PCL/
PVA).
2.4. Characterization of the Scaolds. The prepared nanofi-
brous scaolds were characterized by scanning electron mi-
croscopy. Air-dried samples of electrospun HA-coated nano-
fibers were mounted on aluminum stubs and sputter-coated
with a layer of gold approximately 60 nm thick using a
Polaron sputter-coater (SC510, Polaron, Now Quorum Tech-
nologies Ltd.). The samples were examined in an Aquasem
(Tescan) scanning electron microscope in the secondary elec-
tron mode at 15 kV.
2.5. Biomechanical Characterization of Scaolds. Young’s
moduli of elasticity, ultimate stresses, and ultimate strains
of the scaolds were obtained at room temperature using a
Zwick/Roell traction machine equipped with a 1 kN load cell.
Because of the diculty to produce the layer of PCL/PVA na-
nofibers of uniform thickness, only the samples with the
same thickness of the basic layer of PCL/PVA nanofibers of
pure samples as well as with the layer of HA were used for
mechanical testing. Thus, the samples without layer of HA
were signed as type I (n = 4) and with the HA layer as
type II (n = 7). The samples themselves were thin strips of
the nanofibers. The initial length of all samples was 10 mm.
The width of all samples was 10 mm. The thickness of in-
dividual samples was about 60 µm. The samples were pre-
pared according to studies [54, 55]. The template of the paper
20 × 50 mm (height × width) with the centered rectangular
hole 10 × 40 mm was cut, and lines marking 10 mm wide
sample strips were drawn on its top and bottom stripes. Then
it was glued to the sheet of the composite, and two other
strips of paper 5 × 50 mm were glued to the back faces of the
top and bottom stripes. Then the individual scaolds were
cut resulting in four 20 × 10 mm stripes consisting of 10 ×
10 mm sample between two 5 × 10 mm grips of paper.
The tensile test with a loading velocity of 10 mm/min was
applied to the samples. The load was applied until the scaf-
fold ruptured. Young’s moduli of elasticity were determin-
ed using linear regression of the stress-strain curves at a
strain of approximately 1–6% (linear region depending on
the shape of the curve). The ultimate stress and the ultimate
strain were determined at the start of the rupture. The stress
was defined as the force divided by the initial area, and the
strain was defined as the elongation of the specimen divided
by its initial length. Our own software written in Python pro-
gramming language was used for evaluation [56].
2.6. Isolation and Cultivation of MSCs. Blood marrow aspi-
rates were obtained from the os ilium (tuber coxae Ala ossis
iili) of anesthetized miniature pigs (age 6–12 months). The
bone marrow blood was aspirated into a 10 mL syringe with
5 mL Dulbecco’s phosphate buered saline (PBS), 2% fetal
bovine serum (FBS), and 25 IU heparin/mL connected with
a bioptic needle (15 G/70 mm). Under sterile conditions, the
bone marrow blood (about 20 mL) was placed into 50 mL
centrifuge tubes and 5 mL of gelofusine was added. After
30 min incubation at room temperature, the blood was cen-
trifuged at 400×g for 15 min. Subsequently, the layer of mo-
nonuclear cells was removed and seeded into a culture flask,
then cultured at 37◦C in a humidified atmosphere with 5%
CO2. α-MEM medium with Earle’s Salt and L-glutamine
supplemented with 10% FBS and penicillin/streptomycin
(100 IU/mL and 100 µg/mL, resp.) was used as the culture
medium.
2.7. MSCs Seeding on the Scaolds. Scaolds were cut into
a round shape with a diameter of 6 mm and sterilized using
ethylenoxid. Cells were seeded on the scaolds at a density
of 70 × 103/cm2 in a 96-well plate. Scaolds with seeded
MSCs were cultivated in dierentiation media: α-MEM sup-
plemented with 10% FBS, penicillin/streptomycin (100 IU/
mL and 100 µg/mL, resp.), 100 nM dexamethasone, 40 µg/
mL ascorbic acid-2-phosphate and 10 nM glycerol 2-phos-
phate disodium salt hydrate. The medium was changed ev-
ery 3 days.
2.8. Cell Proliferation Analysis by the MTT Test. 50 µL of
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide] (MTT), and 1 mg/mL in PBS (pH 7.4) were added
to 150 µL of sample medium and incubated for 4 hours at
37◦C. The MTT was reduced by the mitochondrial dehydro-
genase of normally metabolizing cells to purple formazan.
Formazan crystals were solubilized with 100 µL of 50% N,N-
dimethylformamide in 20% sodium dodecyl sulfate (SDS) at
pH 4.7. The results were examined by spectrophotometry in
an ELISA reader at 570 nm (reference wavelength 690 nm).
2.9. Cell Proliferation Analysis by PicoGreen. The PicoGreen
assay was carried out using the Invitrogen PicoGreen assay
kit (Invitrogen Ltd., Paisley, UK). The proliferation of MSCs
on scaolds was tested on days 1, 7, and 14. To process
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material for the analysis of DNA content, 250 µL of cell
lysis solution (0.2% v/v Triton X-100, 10 mM Tris (pH 7.0),
1 mM EDTA) was added to each well containing a scaf-
fold sample. To prepare the cell lysate, the samples were pro-
cessed through a total of three freeze/thaw cycles, scaold
sample was first frozen at −70◦C and thawed at room tem-
perature. Between each freeze/thaw cycle scaolds were
roughly vortexed. Prepared samples were stored at −70◦C
until analysis. To quantify cell number on scaolds, a cell-
based standard curve was prepared using samples with
known cell numbers (range 100–106 cells). The DNA content
was determined by mixing of 100 µL PicoGreen reagent and
100 µL of DNA sample. Samples were loaded in triplicate
and florescence intensity was measured on a multiplate fluo-
rescence reader (Synergy HT, λex = 480–500 nm, λem = 520–
540 nm). Measured data were used for derivation of ab-
sorbance values measured by MTT assay to cell counts on
the scaolds.
2.10. Viability of Cells Seeded on Scaolds. For determining
cell viability, live/dead staining (BCECF-AM/propidium io-
dide) and visualization using confocal microscopy was per-
formed. 2′, 7′-bis(2carboxyethyl)-5(6)-carboxyfluorescein
acetoxymethyl ester (BCECF-AM, diluted 1 : 100 in medium)
was added to cell-seeded scaolds and incubated for 45 min
at 37◦C and 5% CO2 for live cell detection, then rinsed with
PBS (pH 7.4); propidium iodide (5 µg/mL in PBS pH 7.4)
was added for 10 min, rinsed with PBS (pH 7.4) again, and
visualized using a Zeiss LSM 5 DUO confocal microscope
(wavelengths: BCECF-AM λexc = 488 nm and λem = 505–
535 nm; propidium iodide λexc = 543 nm and λem = 630–
700 nm).
2.11. Quantitative Real-Time PCR Analysis. Total RNA was
extracted using an RNeasy Mini Kit according to the manu-
facturer’s protocol. Total RNA was stored at –20◦C.
The cDNA from 1 µg of total RNA was used as a tem-
plate. The synthesis of cDNA was performed by a standard
procedure described in our previous work [57]. Bone sialo-
protein (BS) and osteocalcin (OC) mRNA expression levels
were quantified by means of a LightCycler 480 (Roche Dia-
gnostics, Mannheim, Germany) using the double-strand-
specific dye SYBR Green I according to the manufacturer’s
protocol. Primers used were as follows: BS, sense 5′-CGA
CCA AGA GAG TGT CAC-3′, antisense 5′-GCC CAT TTC
TTG TAG AAG C-3′ (498 bp); OC, sense 5′-TCA ACC CCG
ACT GCG ACG AG-3′, antisense 5′-TTG GAG CAG CTG
GGA TGA TGG-3′ (204 bp) and beta-actin, sense 5′-AGG
CCA ACC GCG AGA AGA TGA CC-3′, antisense 5′-GAA
GTC CAG GGC GAC GTA GCA C-3′ (332 bp). The PCR
conditions were initial denaturation at 95◦C for 10 min, fol-
lowed by 45 cycles of denaturation at 95◦C for 15 s, annealing
at 57◦C for 10 s, and extension at 72◦C for 20 s. The ex-
pression levels of BS and OC mRNAs were normalized using
the level of beta-actin mRNA as a housekeeping gene and
expressed as the ratio to actin. Student’s t-test was used to
evaluate the statistical significance of the results. Dierences
with P values <0.05 were considered significant.
2.12. Measurement of FITC-Dextran Release Profile. In order
to study the release profile of FITC-dextran, core-shell nano-
fiber meshes with either 1% PVA, 3% PVA, or 5% PVA were
cut into round patches and incubated with 1 mL of TBS
buer at room temperature. At specific intervals, the TBS
buer was withdrawn and replaced with fresh buer. The
time interval was determined keeping in mind the balance
between the release of a detectable amount of FITC-dextran
and maintenance of the sink condition. Drug release was
quantified using fluorescence spectroscopy. Briefly, 200 µL of
samples and blank samples were measured on a multiplate
fluorescence reader (Synergy HT, λex = 480–500 nm, λem =
520–540 nm) and background subtraction was performed.
The cumulative release profile of FITC-dextran was obtained,
and the half time of release was determined as the time at
which the initial fluorescence intensity I0 decreased to I =
I0 · e−1.
2.13. Statistical Analysis. Quantitative data are presented as
mean ± standard deviation (SD). For in vitro tests, average
values were determined from at least three independently
prepared samples. Results were evaluated statistically using
one-way analysis of variance (ANOVA) and the Student-
Newman-Keuls Method. The Shapiro-Wilk’s W test was used
to determine the normality of the Young’s moduli of elas-
ticity, ultimate strains, and ultimate stresses. The t-test was
used to determine the dierences between values of mech-
anical parameters obtained for pure PCL/PVA scaolds (type
I) and scaolds covered by HA (type II).
3. Results and Discussion
3.1. Scaold Characterization. Coaxial core-shell nanofibers
were prepared from PCL as a shell material and PVA as a core
material. PCL has good biocompatibility and enables the suc-
cessful cultivation of MSCs [58] and osteogenic cells [59]. On
the other hand, PVA is a water-soluble material and has been
employed as a suitable substance for the delivery of bioactive
compounds from the nanofiber core [60]. To improve the
surface parameters for MSCs seeding, coaxial nanofibers
were further functionalized by pulsed laser deposition of HA.
Thin layers of 200, 400, or 800 nm thickness were deposited
onto the nanofiber surface. HA deposition clearly modified
the nanofiber surface and significantly influenced the surface
properties. Scanning electron microscopy revealed the
fibrous morphology of PCL nanofibers (Figure 1(a)). This
is in accordance with our previous results [61]. Pulsed laser
deposition of a 200 nm thick HA layer did not aect the fi-
brous morphology or porosity of the nanofibers (Figure
1(b)). However, the fibrous character of samples with a
400 nm thick HA layer (Figure 1(c)) was less well preserved,
and the porosity of the scaold decreased. The fibrous mor-
phology disappeared completely in samples with a 800 nm
thick HA coating (Figure 1(d)).
3.2. Biomechanical Testing. The eect of an HA layer on the
biomechanical properties of the nanofibers was tested us-
ing a tensile test. Young’s moduli of elasticity, the ultimate
stresses, and the ultimate strains of scaolds of PCL/PVA
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Figure 1: Visualization of scaolds by SEM and confocal microscopy. Prepared scaolds were visualized using SEM (a, b, c, d). On day 7,
MSCs were stained using BCECF-AM and propidium iodide for live/dead staining, and samples were visualized by confocal microscopy (e,
f, g, h); PCL/PVA (a, e), PCL/PVA200HA (b, f), PCL/PVA400HA (c, g), and PCL/PVA800HA (d, h).
nanofibers and various amounts of HA were determined at
room temperature using a Zwick/Roell traction machine. We
found significant dierences in Young’s moduli of elasticity
between samples without an HA layer and those with an HA
layer (P = 0.04). Young’s moduli of elasticity in the case of
pure PCL/PVA nanofibers was 1.76 ± 0.50 Mpa while that
for the samples with an HA layer was 5.40 ± 3.09 MPa; the
dierence was significant (see Figure 4(a)). Significant dier-
ences between these two groups were found as well in the case
of ultimate strains (P < 0.001). Here, the value obtained for
pure PCL/PVA scaolds was 0.23 ± 0.03, while for scaolds
with an HA layer the value was 0.09±0.04, (see Figure 4(b)).
No significant dierences were found when analyzing ulti-
mate stresses (P = 0.26), although the value for the
group with an HA layer, 0.36 ± 0.27 MPa, was higher than
that for the pure PCL/PVA scaolds, 0.19 ± 0.07 MPa (see
Figure 4(c)). The results showed that from the mechanical
point of view, a PCL/PVA scaolds covered by an HA layer
is the relevant choice as a scaold material for other studies
and applications in which greater stiness is required.
3.3. Proliferation and Viability of MSCs Seeded on Scaolds.
To test the scaolds’ biocompatibility and their ability to
stimulate the proliferation and dierentiation of MSCs into
osteogenic cells, MSCs were seeded on scaolds and culti-
vated for 14 days. Their proliferation and viability were deter-
mined on days 1, 7, and 14. Cell proliferation was determined
by the PicoGreen assay and confocal microscopy (Figure 2).
Viability was determined by the widely used MTT assay.
Clearly, the deposition of a 400 nm or 800 nm thick HA layer
resulted in the highest absorbance, which in turn reflected
the best cell viability. However, some publications have
reported that the MTT test is aected by cell number [62]. In
order to correct for the possible inaccuracy of the MTT as-
say, we performed the PicoGreen assay as well. PicoGreen is
a highly sensitive probe for dsDNA and thus can be used to
determine cell numbers. Consequently, we performed both
the MTT assay and the PicoGreen assay and correlated both
results. This approach enabled the calibration of the absor-
bance measured in the MTT assay to the cell number deter-
mined by PicoGreen. By comparing the results of both assays
in this manner, we were able to derive reliable data on cell
viability (Figure 2). The results showed that in the control
samples (PCL/PVA), cell viability was only slightly elevated.
On the other hand, samples coated with HA showed a mark-
ed increase in cell viability. The highest viability was detected
for samples with a 400 nm or 800 nm thick HA coating.
This conclusion was clearly supported by our confocal
microscopy observations. MSC viability on the scaolds was
characterized by BCECF-AM and propidium iodide in the
presence of an HA coating (Figures 1(e)–1(h)). The largest
cell population was found in the samples with an 800 nm
thick HA coating (Figure 1(h)), which is in agreement with
the results of the PicoGreen assay.
3.4. Osteogenic Dierentiation of MSCs. A positive influence
of HA on osteogenesis has been demonstrated in many re-
ports [4, 63, 64]. On the other hand, Wang et al. pointed out
the significance of HA structures for proliferation and found
higher cell proliferation rates on microsized HA particles
than on nanosized ones [65]. Ribeiro et al. also found
improved cell viability and proliferation of osteoblastic
6 Journal of Biomedicine and Biotechnology
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Figure 2: Cell metabolic activity and viability. Metabolic activity of viable MSCs was detected by MTT assay on day 1, 7, and 14 (mean ±
standard deviation). Results of MTT assay for PCL/PVA, PCL/PVA200HA, PCL/PVA400HA, and PCL/PVA800HA samples (a). Cell viability
calculated as derivation of absorbance values from MTT assay to cell counts determined by PicoGreen assay (b).
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Figure 3: Expression of BS (a) and OC (b) genes. Osteogenic dierentiation of MSCs was detected by PCR analysis of expresion BS and OC
genes on day 7 and 14 (mean ± standard deviation).
MC3T3-E1 cells on HA particles of larger size [66]. However,
there is no clear evidence so far on the eect of HA on dier-
entiation into osteogenic cells. Therefore, the eect of HA
coating of nanofibers on the osteogenic dierentiation of
MSCs was studied using real-time PCR analysis. The expres-
sion levels of BS and OC mRNAs, osteogenic markers, were
detected on day 7 and 14 for all samples (Figures 3(a) and
3(b)). Interestingly, the samples with an 800 nm thick HA
coating were characterized by the significantly higher expres-
sion of BS and OC genes than the pure PCL/PVA samples.
Based on our results, we can hypothesize that HA-modified
nanofibers induced cell dierentiation and also improved cell
viability (Figure 2).
3.5. Release Profile of FITC-Dextran. Besides surface modif-
ications, possibilities exist for drug distribution into the
nanofiber core. The encapsulation of dierent proliferation
agents inside the nanofibers can increase their ability to stim-
ulate proliferation and thus further improve the positive
eect of nanofiber scaolds on MSCs proliferation and dif-
ferentiation. This could be especially important in combi-
nation with the already described positive eect of HA de-
position on MSCs viability and dierentiation. Knowledge of
the release profile from HA-coated nanofibers seems to be a
key point for the construction of novel drug-delivery systems
suitable for bone tissue engineering.
To study the release profile from coaxially electrospun
nanofibers with dierent concentrations of core polymer,
FITC-dextran incorporated into the nanofiber core was
employed as the monitoring fluorescence probe. The FITC-
dextran samples were incubated at room temperature in TBS
buer, which was subsequently replaced with fresh buer as
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Figure 4: The moduli of elasticity, the ultimate strain, and ultimate stress of the group of pure PCL/PVA composite (type I) and the group
of the PCL/PVA composite covered by HA layer (type II). There is a significant dierence in the moduli of elasticity between these groups
(determined by t-test; P = 0.04) (a) and also in the ultimate strain (P < 0.001) (b), but not in the ultimate stress (P = 0.26) (c). Mean is the
mean value, SE is the standard error.
described in Section 2. The collected fractions were analyzed
by fluorescence spectroscopy, and the cumulative release pro-
file of FITC-dextran was calculated (Figure 5). The half-time
of release from coaxial nanofibers was strongly dependent
on the presence of a hydrophilic core polymer. Core/shell
nanofibers containing FITC-dextran dissolved in 1% PVA
showed the highest burst release (79% of FITC-dextran
released in 24 h). The half time of release was calculated as
τr = 18 h. The release of FITC/dextran from fibers with
3% PVA showed a slower release; however, an intense burst
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Figure 5: Time-dependent release profile of coaxial PCL/PVA na-
nofibers. Release of FITC-dextran from samples with dierent con-
tent of PVA core was analyzed using fluorescence spectroscopy.
Samples were analyzed for 240 h, and supernatants were collected
in 24 h intervals (mean ± standard deviation).
release was observed (65% of FITC-dextran released in 24 h).
The half-time of release was prolonged to 24 h. Interestingly,
samples with 5% PVA as the core polymer showed the most
sustained release profile. The burst release was reduced to
52% of FITC-dextran release in 24 h, and the half-time of
release was shifted to 54 h. The results clearly show that dif-
ferent concentrations of the water-soluble core significantly
aect the release profiles of incorporated substances.
4. Conclusion
Pulsed laser deposition was proven to be a suitable method
for HA coating of coaxial PCL/PVA nanofibers. The fibrous
morphology of PCL/PVA nanofibers was preserved when
the nanofiber scaold was coated with thin layers of HA
(200 nm and 400 nm). Increasing the thickness of HA,
however, resulted in a gradual loss of this fibrous character.
In addition, the biomechanical properties were improved
after HA deposition on PCL/PVA nanofibers as the value of
Young’s moduli of elasticity significantly increased after HA
deposition.
The proliferation and dierentiation of MSCs on HA-
coated scaolds are separate processes. Our HA-coated na-
nofiber scaolds clearly displayed a positive eect on the dif-
ferentiation of MSCs into osteogenic cells but not on cell pro-
liferation. The moderate eect of HA-coated nanofiber scaf-
folds on cell proliferation observed in our study could be im-
proved, however, by exploiting core/shell nanofibers. Such a
delivery system, based on coaxial spinning, can encapsulate
proliferation stimulating factors that could be subsequently
steadily released. This system seems to be a potentially pro-
mising one for the development of artificial bone tissue and
bone healing. To conclude, thin-layer hydroxyapatite depo-
sition on a nanofiber surface stimulated mesenchymal stem
cell proliferation and their dierentiation into osteoblasts.
The 800 nm HA layer was demonstrated to be optimal for
bone tissue engineering application.
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